// App-Quantinova.ai

1722 : Identification of a Sub-Population of Autoantibodies Targeting BICD2 Cross-Reacting with CENP-a Derived Peptides in Patients with Systemic Sclerosis

Researchers

Presenter

  • Michael Mahler

Principal Investigators

  • Chelsea Bentow

  • May Choi

  • Mianbo Wang

  • Petra Budde

  • Murray Baron

  • Marie Hudson

  • Marvin J. Fritzler

Medical Centers

  • Jay Milo

  • Research and Development, Inova Diagnostics, San Diego, CA, United States

  • University of Calgary, Calgary, AB, Canada

  • Lady Davis Institute for Medical Research, Montreal, QC, Canada

  • Protagen AG, Dortmund, Germany

  • Jewish General Hospital, Montreal, QC, Canada

  • Division of Rheumatology, Jewish General Hospital, Lady Davis Institute for Medical Research, Montreal, QC, Canada

  • Internal Medicine, University of Calgary, Calgary, AB, Canada

Locations

  • United States

  • Canada

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • Centromere protein A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A